CHI Advisors LLC
- SEC CIK
- 0001791468
- Latest filing
- Nov 13, 2023
Holdings in Q3 2021
Holdings as of Sep 30, 2021, filed Nov 15, 2021. Long positions only; changes compare share counts with Q2 2021.
- Positions
- 19
- +1 vs. Q2 2021
- Portfolio value
- $342.6M
- −$87.3M (−20.3%) vs. Q2 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| KROSKeros Therapeutics, Inc. | COM | 12,627 | $500.0K | 0.1% | −103,779−89.2% | Reduced | History |
| KZRKezar Life Sciences, Inc. | COM | 75,000 | $648.0K | 0.2% | −71,680−48.9% | Reduced | History |
| GTHXG1 Therapeutics, Inc. | COM | 50,000 | $671.0K | 0.2% | 00.0% | Unchanged | History |
| OVIDOvid Therapeutics Inc. | COM | 233,510 | $785.0K | 0.2% | +15,000+6.9% | Added | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 165,927 | $803.0K | 0.2% | −553,205−76.9% | Reduced | History |
| IMAImageneBio, Inc. | COM | 315,000 | $3.98M | 1.2% | −499,756−61.3% | Reduced | History |
| Freeline Therapeutics Hldgs35655L107 | SPONSORED ADS | 1,427,481 | $4.87M | 1.4% | +47,638+3.5% | Added | – |
| DTILPrecision Biosciences Inc | COM | 646,729 | $7.46M | 2.2% | −5,000−0.8% | Reduced | History |
| ORTXOrchard Therapeutics plc | ADS | 4,081,972 | $9.39M | 2.7% | 00.0% | Unchanged | History |
| AKUSAkouos, Inc. | COM | 858,027 | $9.96M | 2.9% | 00.0% | Unchanged | History |
| INZYInozyme Pharma, Inc. | COM | 920,264 | $10.7M | 3.1% | −7,000−0.8% | Reduced | History |
| ONCROncorus, Inc. | COM | 1,755,979 | $16.4M | 4.8% | +20,000+1.2% | Added | History |
| LRMRLarimar Therapeutics, Inc. | COM | 1,515,148 | $17.5M | 5.1% | 00.0% | Unchanged | History |
| OMGAOmega Therapeutics, Inc. | COMMON STOCK | 1,055,882 | $19.9M | 5.8% | +1,055,882 | New | History |
| Vectivbio Hldg AGH9060V101 | ORD SHS | 2,592,602 | $20.0M | 5.8% | +6,616+0.3% | Added | – |
| PLRXPliant Therapeutics, Inc. | COM | 2,484,724 | $41.9M | 12.2% | +116,836+4.9% | Added | History |
| CGEMCullinan Therapeutics, Inc. | COM | 2,244,841 | $50.7M | 14.8% | +2,000+0.1% | Added | History |
| RPTXRepare Therapeutics Inc. | COM | 2,232,783 | $58.6M | 17.1% | −306,861−12.1% | Reduced | History |
| RXDXPrometheus Biosciences, Inc. | COM | 2,862,059 | $67.9M | 19.8% | +10,050+0.4% | Added | History |